The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes

Raymond Konger, Sabine Brouxhon, Steven Partillo, JoAnne VanBuskirk, Alice P. Pentland

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Primary human keratinocytes (PHKs) are known to express the EP3 subtype of prostaglandin E2 receptor. To better understand the role of EP3 receptors in regulating epidermal function, we characterized their expression, localization, and signaling effects in human skin. Three different splice variants of the EP3 receptor (EP3A1, EP3C, and EP3D) were found to be expressed. Immunohistochemical analysis of human skin demonstrated that EP3 receptors were most prominently expressed in the basal and lower spinous layers of the epidermis. The EP3 receptor agonist sulprostone was then used to examine EP3 receptor-dependent keratinocyte signaling pathways and functional effects. We observed that sulprostone inhibits keratinocyte growth at doses between 0.02 and 2 nM and induces sn- 1,2-diacylglycerol (DAG) and ceramide production. Concurrent expression of the cell-cycle inhibitory protein p21WAF1 also occurred. These data suggest that EP3 receptors produce epidermal growth inhibition through the action of DAG and ceramide second messengers.

Original languageEnglish (US)
Pages (from-to)914-922
Number of pages9
JournalExperimental Dermatology
Volume14
Issue number12
DOIs
StatePublished - Dec 2005

Fingerprint

Ceramides
Diglycerides
Keratinocytes
Receptors, Prostaglandin E, EP3 Subtype
Skin
Growth
Cell Cycle Proteins
Second Messenger Systems
Epidermis
sulprostone
1,2-diacylglycerol

Keywords

  • Ceramide
  • Diacylglycerol
  • EP receptors
  • Growth inhibition
  • Immunolocalization

ASJC Scopus subject areas

  • Dermatology

Cite this

The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes. / Konger, Raymond; Brouxhon, Sabine; Partillo, Steven; VanBuskirk, JoAnne; Pentland, Alice P.

In: Experimental Dermatology, Vol. 14, No. 12, 12.2005, p. 914-922.

Research output: Contribution to journalArticle

Konger, Raymond ; Brouxhon, Sabine ; Partillo, Steven ; VanBuskirk, JoAnne ; Pentland, Alice P. / The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes. In: Experimental Dermatology. 2005 ; Vol. 14, No. 12. pp. 914-922.
@article{b5672d042a294cd7b0fbb998044e88ca,
title = "The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes",
abstract = "Primary human keratinocytes (PHKs) are known to express the EP3 subtype of prostaglandin E2 receptor. To better understand the role of EP3 receptors in regulating epidermal function, we characterized their expression, localization, and signaling effects in human skin. Three different splice variants of the EP3 receptor (EP3A1, EP3C, and EP3D) were found to be expressed. Immunohistochemical analysis of human skin demonstrated that EP3 receptors were most prominently expressed in the basal and lower spinous layers of the epidermis. The EP3 receptor agonist sulprostone was then used to examine EP3 receptor-dependent keratinocyte signaling pathways and functional effects. We observed that sulprostone inhibits keratinocyte growth at doses between 0.02 and 2 nM and induces sn- 1,2-diacylglycerol (DAG) and ceramide production. Concurrent expression of the cell-cycle inhibitory protein p21WAF1 also occurred. These data suggest that EP3 receptors produce epidermal growth inhibition through the action of DAG and ceramide second messengers.",
keywords = "Ceramide, Diacylglycerol, EP receptors, Growth inhibition, Immunolocalization",
author = "Raymond Konger and Sabine Brouxhon and Steven Partillo and JoAnne VanBuskirk and Pentland, {Alice P.}",
year = "2005",
month = "12",
doi = "10.1111/j.1600-0625.2005.00381.x",
language = "English (US)",
volume = "14",
pages = "914--922",
journal = "Experimental Dermatology",
issn = "0906-6705",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes

AU - Konger, Raymond

AU - Brouxhon, Sabine

AU - Partillo, Steven

AU - VanBuskirk, JoAnne

AU - Pentland, Alice P.

PY - 2005/12

Y1 - 2005/12

N2 - Primary human keratinocytes (PHKs) are known to express the EP3 subtype of prostaglandin E2 receptor. To better understand the role of EP3 receptors in regulating epidermal function, we characterized their expression, localization, and signaling effects in human skin. Three different splice variants of the EP3 receptor (EP3A1, EP3C, and EP3D) were found to be expressed. Immunohistochemical analysis of human skin demonstrated that EP3 receptors were most prominently expressed in the basal and lower spinous layers of the epidermis. The EP3 receptor agonist sulprostone was then used to examine EP3 receptor-dependent keratinocyte signaling pathways and functional effects. We observed that sulprostone inhibits keratinocyte growth at doses between 0.02 and 2 nM and induces sn- 1,2-diacylglycerol (DAG) and ceramide production. Concurrent expression of the cell-cycle inhibitory protein p21WAF1 also occurred. These data suggest that EP3 receptors produce epidermal growth inhibition through the action of DAG and ceramide second messengers.

AB - Primary human keratinocytes (PHKs) are known to express the EP3 subtype of prostaglandin E2 receptor. To better understand the role of EP3 receptors in regulating epidermal function, we characterized their expression, localization, and signaling effects in human skin. Three different splice variants of the EP3 receptor (EP3A1, EP3C, and EP3D) were found to be expressed. Immunohistochemical analysis of human skin demonstrated that EP3 receptors were most prominently expressed in the basal and lower spinous layers of the epidermis. The EP3 receptor agonist sulprostone was then used to examine EP3 receptor-dependent keratinocyte signaling pathways and functional effects. We observed that sulprostone inhibits keratinocyte growth at doses between 0.02 and 2 nM and induces sn- 1,2-diacylglycerol (DAG) and ceramide production. Concurrent expression of the cell-cycle inhibitory protein p21WAF1 also occurred. These data suggest that EP3 receptors produce epidermal growth inhibition through the action of DAG and ceramide second messengers.

KW - Ceramide

KW - Diacylglycerol

KW - EP receptors

KW - Growth inhibition

KW - Immunolocalization

UR - http://www.scopus.com/inward/record.url?scp=28444491736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28444491736&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0625.2005.00381.x

DO - 10.1111/j.1600-0625.2005.00381.x

M3 - Article

C2 - 16274459

AN - SCOPUS:28444491736

VL - 14

SP - 914

EP - 922

JO - Experimental Dermatology

JF - Experimental Dermatology

SN - 0906-6705

IS - 12

ER -